CAPTRUST Financial Advisors
PRCT icon

CAPTRUST Financial Advisors’s Procept Biorobotics PRCT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-74
Closed -$2K – 3519
2022
Q2 		$2K Buy
74
+7
+10% +$255 ﹤0.01% 4500
2022
Q1 		$2K Buy
+67
New +$1.61K ﹤0.01% 4525

Other funds holding PRCT

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CAPTRUST Financial Advisors's PRCT Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Procept Biorobotics (PRCT) in Q3 2022, closing a stake of 74 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in PRCT in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 103 funds tracked by Wall St. Rank hold PRCT as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Procept Biorobotics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 74 Procept Biorobotics shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Procept Biorobotics in Q1 2022 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Procept Biorobotics position peaked at $2K in Q2 2022.
  • 103 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.